Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

Share Price is delayed by 15 minutes
Get Live Data
6.35    -0.15 (-2.31%)
Bid:
6.20
Ask:
6.50
Spread: 0.30 (4.839%)
Market Cap: £68.79m
ANIC Live PriceLast checked at - London Stock Exchange

Intraday Agronomics Share Chart

Net Asset Value(s)

8 Oct 2019 07:00

RNS Number : 0508P
Agronomics Limited
08 October 2019
Β 

8 October 2019

Agronomics Limited

(the "Company")

Net Asset Value calculation to 30 September 2019

Richard Reed, Chairman, commented: -

"The Net Asset Value ("NAV") calculation for the Company as at closing on 30 September 2019 was 5.50 pence per share, including un-invested cash of Β£3,463,359. The portfolio is valued under IFRS at bid price. I am pleased to note that the share price of 6.75 pence at 30 September 2019 close represents a premium of 22% to the NAV. Net Assets stand at Β£6.3 million, including investments of Β£2.8 million. This quarter's NAV per share represents a decrease of 23% from the previous valuation of 7.17 pence per share, which included un-invested cash of Β£417,952. The reduction is largely as a result of the increase in issued shares following the fundraise. No management fee is due to Shellbay Investments Limited.

Following completion of a successful fundraise during July 2019, the proceeds are now available for deployment in line with the new investment policy.

On 29 July 2019, the Company completed a subscription of US$ 699,999.54 for 885,739 Series Seed Preferred Shares in Simply Foods, Inc. ("Simply Foods") trading asΒ New Age Meats, a company based in San Francisco, California, USA, that is developing pork-based cultured meat products.Β The Subscription was part of the first close of the Series Seed funding round to raise a minimum of US$ 2.0 million undertaken by Simply Foods, led by New York-based ff Graphite (V) Venture Capital Fund, LP. The Company was the only European based investor participating in this round, and remains the only UK quoted vehicle offering investors exposure to this rapidly growing sector.

On 29 August 2019, the Company completed a subscription of US$ 749,990 for 40,540 Series A Preferred Shares in BlueNalu, Inc. ("BlueNalu"), a global leader in cellular aquaculture. The subscription increased the Company's existing interest in BlueNalu to approximately 2.59%. The subscription was part of the Series A funding round undertaken by BlueNalu, and co-led by Stray Dog Ventures LLC, Clear Current Capital Fund, LLC, CPT Capital Fund, LLP and New Crop Capital Trust - four prominent investors in the alternative protein sector. The price per share of the subscription represented a multiple uplift of approximately 3.2x since the Company's original investment in BlueNalu of US$250,000 in August 2018.

On 5 September 2019, the Company subscribed for US $150,000 of convertible promissory notes inΒ Bond Pets LLC ("Bond").Β Bond makes laboratory-grown meat using fermentation for the pet food market. The subscription would translate to an approximate 3% to 4% equity interest in Bond, dependent on the valuation of Bond upon conversion.

Β 

Your board continues to evaluate a number of opportunities which show significant growth prospects".

Unaudited to

30 September 2019 Β£

Fixed Assets

Investments

2,827,203

Current Assets

Uninvested cash

3,463,359

Sundry Debtors

34,355

Current Liabilities

Trade and other creditors

(61,841)

6,263,076

Capital and Reserves

Share Capital

23

Share Premium

6,420,142

Reserves

(157,089)

6,263,076

Shares in Issue

113,795,558

Net Asset Value per share

5.50 pence

Β 

Β 

Portfolio Details

Investments as at 30 September 2019

Value

% of Total Portfolio

AgeX Therapeutics Inc

197,193

6.97%

Regent Pacific Group Limited

210,871

7.46%

Portage Biotech Inc

216,845

7.67%

Other quoted holdings

7,627

0.27%

Other unquoted holdings

2,194,667

77.63%

Total

2,827,203

100.00%

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR'). Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.Β 

Β 

For further information, please contact:

Agronomics Limited

Beaumont Cornish Limited

Optiva Securities Limited

Peterhouse Capital Limited

Britton Financial PR

The Company

Nomad

Joint Broker

Joint Broker

Investor Relations

Denham Eke

+44 (0) 1624 639396

Roland Cornish/James Biddle

+44 (0) 207 628 3396

Jeremy King

+44 (0) 203 137 1904

Lucy Williams

+44 (0) 207 469 0936

Β 

Tim Blackstone

+44 (0)7957 140416

Β 

ENDS

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
NAVBLBDGUBGBGCR
Date   Source Headline
11th May 202111:05 amRNSSecond Price Monitoring Extn
11th May 202111:00 amRNSPrice Monitoring Extension
11th May 202110:40 amRNSProposed Fundraise to raise £50 million
6th May 20212:30 pmRNSNew Consultancy Agreement with Shellbay
21st Apr 20218:30 amRNSInvestee Company Update: LegenDairy Foods
21st Apr 20217:00 amRNSNet Asset Value calculation to 31 March 2021
8th Apr 202110:47 amRNSInvestee Company Update: Solar Foods
30th Mar 20217:00 amRNSInvestee Company Update: LIVEKINDLY Fundraise
23rd Mar 20213:00 pmRNSMeatable Announces US$ 47 Million Financing
15th Mar 20212:06 pmRNSSecond Price Monitoring Extn
15th Mar 20212:01 pmRNSPrice Monitoring Extension
15th Mar 202111:05 amRNSSecond Price Monitoring Extn
15th Mar 202111:00 amRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSPortfolio Company Update: LIVEKINDLY Collective
25th Feb 20217:00 amRNSAnnounces Further Investment in VitroLabs
18th Feb 20217:00 amRNSAnnounces Further Investment in Meatable
11th Feb 20217:00 amRNSInvestee Company Update: New Age Meats
3rd Feb 20217:00 amRNSResult of AGM
26th Jan 20217:00 amRNSHalf-year Report
20th Jan 20217:00 amRNSInvestee Company Update: BlueNalu Secures $60m
19th Jan 20213:33 pmRNSExercise of Warrants
18th Jan 20217:00 amRNSNet Asset Value calculation to 31 December 2020
16th Dec 20207:00 amRNSInvestment in SuperMeat
14th Dec 20207:00 amRNSFinal Results
9th Dec 20207:00 amRNSInvestment in CellX
7th Dec 20201:00 pmRNSPortfolio Update: Mosa Meat
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:00 pmRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSPortfolio Update: Solar Foods receives EUR4.3m
19th Nov 20207:00 amRNSAnnounces Investment of US$ 5 million in BlueNalu
11th Nov 20202:59 pmRNSAgronomics November Newsletter 2020
10th Nov 20209:46 amRNSClosure of Broker Option & TVR
2nd Nov 20207:00 amRNSHolding(s) in Company
26th Oct 20207:00 amRNSEquity Fundraise of £10.0 million
15th Oct 20207:30 amRNSInvestee Company Update: LIVEKINDLY Collective
15th Oct 20207:00 amRNSNet Asset Value(s)
29th Sep 20202:54 pmRNSPortfolio Company Shiok Meats completes Financing
29th Sep 20207:00 amRNSAppointment of Joint Broker
25th Sep 20207:00 amRNSAnnounces Participation in Mosa Meat Financing
1st Sep 20201:00 pmRNSInvestment in Solar Foods EUR 15million Financing
12th Aug 20207:00 amRNSDirectorate Change
20th Jul 20207:00 amRNSNet Asset Value - 30 June 2020
1st Jul 202012:00 pmRNSConclusion of consultation being to remain on AIM
19th Jun 20207:00 amRNSConsultation on Possible De-Listing & Tender Offer
15th Jun 202012:10 pmRNSHolding(s) in Company
11th Jun 20207:00 amRNSCo-lead of Meatable B.V.’s Seed 2 Financing
14th Apr 20207:00 amRNSNet Asset Value calculation to 31 March 2020
6th Apr 20203:49 pmRNSNEWSLETTER 06/04/2020
2nd Apr 202011:59 amRNSPortfolio Company Update: GALY CO.
2nd Apr 20207:00 amRNSPortfolio Company Update: GALY CO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.